Celltrion
068270.KS
#771
Rank
โ‚น2.176 T
Marketcap
โ‚น10,509
Share price
1.34%
Change (1 day)
-3.91%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of March 2024 : โ‚น136.05 Billion

According to Celltrion 's latest financial reports the company's total debt is โ‚น136.05 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚น51.99 B11.68%
2021-12-31โ‚น46.56 B-10.68%
2020-12-31โ‚น52.13 B70.65%
2019-12-31โ‚น30.54 B-5.59%
2018-12-31โ‚น32.35 B-15.71%
2017-12-31โ‚น38.38 B0.29%
2016-12-31โ‚น38.27 B-14.94%
2015-12-31โ‚น44.99 B-8.02%
2014-12-31โ‚น48.92 B11.39%
2013-12-31โ‚น43.91 B39%
2012-12-31โ‚น31.59 B66.11%
2011-12-31โ‚น19.02 B73.97%
2010-12-31โ‚น10.93 B9.08%
2009-12-31โ‚น10.02 B11.68%
2008-12-31โ‚น8.97 B676.97%
2007-12-31โ‚น1.15 B